Ask AI

Program Content

Activities

  • Biomarker Testing in HRpos HER2neg ABC
    Unmet Needs, Mechanisms of Resistance, and Biomarker Testing in HR+/HER2- Advanced Breast Cancer Progressing on First-line CDK4/6 Inhibitor Plus Endocrine Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2025

    Expires: November 29, 2025

  • SERDs for Advanced Breast Cancer
    Clinical Evidence for Next-Generation Approaches Targeting the Estrogen Receptor
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2025

    Expires: November 29, 2025

  • Targeting PIK3CA AKT PTEN Alterations in ABC
    Targeting PIK3CA/AKT/PTEN Alterations: Key Clinical Trials
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2025

    Expires: November 29, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, Lilly and Stemline Therapeutics, Inc.

AstraZeneca

Lilly

Stemline Therapeutics, Inc.